Amedisys Inc
NASDAQ:AMED
Amedisys Inc
NASDAQ:AMED
Price:
100.99
USD
0.01%
Market Cap:
$3.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Amedisys Inc
NASDAQ:AMED
|
US |
|
Panoramic Resources Ltd
ASX:PAN
|
AU |
|
P
|
PT Era Digital Media Tbk
IDX:AWAN
|
ID |
|
D
|
Daea TI Co Ltd
KOSDAQ:045390
|
KR |
|
TC Energy Corp
TSX:TRP
|
CA |
|
Vmoto Ltd
ASX:VMT
|
AU |
|
K
|
Kailuan Energy Chemical Co Ltd
SSE:600997
|
CN |
|
EQT Corp
NYSE:EQT
|
US |
|
URU Metals Ltd
LSE:URU
|
CA |
|
Sterlite Technologies Ltd
NSE:STLTECH
|
IN |
|
Banco Santander SA
NYSE:SAN
|
ES |
|
Deswell Industries Inc
NASDAQ:DSWL
|
MO |
|
Solutions Capital Management SIM SpA
MIL:SCM
|
IT |
|
RPA Holdings Inc
TSE:6572
|
JP |
|
N
|
Nippon Express Holdings Inc
TSE:9147
|
JP |
|
eXp World Holdings Inc
NASDAQ:EXPI
|
US |
Multiples-Based Value
The Multiples-Based Value of one
AMED
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 100.99 USD,
Amedisys Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AMED Multiples-Based Value
LOCKED
Multiples Across Competitors
AMED Competitors Multiples
Amedisys Inc Competitors
Amedisys Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Amedisys Inc
NASDAQ:AMED
|
3.3B USD | 1.4 | 38.8 | 11.5 | 14.6 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
91.7B USD | 0.2 | 51.6 | 13.5 | 13.5 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
67B EUR | 0.3 | 13.3 | 7.8 | 9.9 | |
| US |
|
Cigna Corp
NYSE:CI
|
71.2B USD | 0.3 | 12 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
25.1B EUR | 1.1 | 19.7 | 9.3 | 13.9 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.3B EUR | 1.1 | 23 | 8.9 | 16.5 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.9B USD | 1.6 | 25.4 | 12.2 | 17.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.6B USD | 2 | 22.1 | 12 | 16.1 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.7B EUR | 0.6 | 11.2 | 5.4 | 9.9 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.3B USD | 11.8 | -27.8 | -30.4 | -27.6 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD | 0.8 | 14.4 | 7.3 | 9.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
